tetradecanoylphorbol acetate has been researched along with Osteopetrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chackalaparampil, I; Lin, PH; Mckee, MD; Mukherjee, AB; Mukherjee, BB; Nemir, M; Peri, A | 1 |
| Key, LL; Ries, WL; Yang, S | 1 |
| Anast, C; Arceci, R; Beard, CJ; Ezekowitz, RA; Key, L; Miller, B; Newburger, PE; Proto, P; Ryan, T; Simons, ER | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and Osteopetrosis
| Article | Year |
|---|---|
Cells in vivo and in vitro from osteopetrotic mice homozygous for c-src disruption show suppression of synthesis of osteopontin, a multifunctional extracellular matrix protein.
Topics: 3T3 Cells; Animals; Base Sequence; Benzoquinones; Bone and Bones; Cell Adhesion; Cell Line; DNA Primers; DNA Replication; Epidermal Growth Factor; ErbB Receptors; Gene Expression; Homozygote; Lactams, Macrocyclic; Mice; Microscopy, Electron; Molecular Sequence Data; Osteopetrosis; Osteopontin; Protein Kinase C; Proto-Oncogene Proteins pp60(c-src); Quinones; Rifabutin; Sialoglycoproteins; Tetradecanoylphorbol Acetate | 1996 |
Superoxide generation in transformed B-lymphocytes from patients with severe, malignant osteopetrosis.
Topics: B-Lymphocytes; Biological Transport; Case-Control Studies; Cell Membrane; Cells, Cultured; Female; Humans; Infant; Infant, Newborn; Male; NADPH Oxidases; Oligonucleotides, Antisense; Osteopetrosis; Phosphorylation; Reference Values; Superoxide Dismutase; Superoxides; Tetradecanoylphorbol Acetate | 1999 |
Neutrophil defect associated with malignant infantile osteopetrosis.
Topics: Flow Cytometry; Hematopoietic Stem Cells; Humans; Infant; Membrane Potentials; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nitroblue Tetrazolium; Osteopetrosis; Superoxides; Tetradecanoylphorbol Acetate | 1986 |